---
title: "Lithium Carbonate - Bipolar Disorder"
sidebar: mydoc_sidebar
permalink: db01356-mesh-d001714-1.html
toc: false 
---


Path ID: `DB01356_MESH_D001714_1`
{% include image.html url="images/db01356-mesh-d001714-1.png" file="db01356-mesh-d001714-1.png" alt="db01356-mesh-d001714-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D016651">MESH:D016651 </a> | Lithium carbonate | Drug |
| <a href="https://identifiers.org/UniProt:P29218">UniProt:P29218 </a> | Inositol monophosphatase 1 | Protein |
| <a href="https://identifiers.org/GO:0046855">GO:0046855 </a> | Inositol phosphate dephosphorylation | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D007294">MESH:D007294 </a> | Inositol | BiologicalProcess |
| <a href="https://identifiers.org/GO:0043647">GO:0043647 </a> | Inositol phosphate metabolic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0014047">GO:0014047 </a> | Glutamate secretion | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P4984">UniProt:P4984 </a> | Glycogen synthase kinase-3 beta | Protein |
| <a href="https://identifiers.org/HP:0000713">HP:0000713 </a> | Agitation | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0061534">GO:0061534 </a> | Gamma-aminobutyric acid secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/GO:0061527">GO:0061527 </a> | Dopamine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/GO:0004972">GO:0004972 </a> | NMDA glutamate receptor activity | MolecularActivity |
| <a href="https://identifiers.org/MESH:D018698">MESH:D018698 </a> | Glutamic Acid | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D001714">MESH:D001714 </a> | Bipolar disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lithium Carbonate | DECREASES ACTIVITY OF | Inositol Monophosphatase 1 |
| Inositol Monophosphatase 1 | POSITIVELY REGULATES | Inositol Phosphate Dephosphorylation |
| Inositol Phosphate Dephosphorylation | INCREASES ABUNDANCE OF | Inositol |
| Inositol | POSITIVELY REGULATES | Inositol Phosphate Metabolic Process |
| Inositol Phosphate Metabolic Process | POSITIVELY REGULATES | Glutamate Secretion |
| Glutamate Secretion | POSITIVELY CORRELATED WITH | Bipolar Disorder |
| Lithium Carbonate | DECREASES ACTIVITY OF | Glycogen Synthase Kinase-3 Beta |
| Glycogen Synthase Kinase-3 Beta | POSITIVELY CORRELATED WITH | Agitation |
| Agitation | OCCURS IN | Bipolar Disorder |
| Lithium Carbonate | POSITIVELY REGULATES | Gamma-Aminobutyric Acid Secretion, Neurotransmission |
| Gamma-Aminobutyric Acid Secretion, Neurotransmission | NEGATIVELY CORRELATED WITH | Bipolar Disorder |
| Lithium Carbonate | NEGATIVELY REGULATES | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | POSITIVELY CORRELATED WITH | Bipolar Disorder |
| Lithium Carbonate | NEGATIVELY REGULATES | Nmda Glutamate Receptor Activity |
| Nmda Glutamate Receptor Activity | POSITIVELY CORRELATED WITH | Glutamic Acid |
| Glutamic Acid | POSITIVELY CORRELATED WITH | Bipolar Disorder |
|---------|-----------|---------|

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/23371914/](https://pubmed.ncbi.nlm.nih.gov/23371914/)
  - [https://go.drugbank.com/drugs/DB14509](https://go.drugbank.com/drugs/DB14509)
  - [https://en.wikipedia.org/wiki/Lithium_(medication)#Bipolar_disorder](https://en.wikipedia.org/wiki/Lithium_(medication)#Bipolar_disorder)
